Macquarie Raises Carmike Cinemas to Outperform (CKEC)
A number of other firms have also recently commented on CKEC. Analysts at Wedbush raised their price target on shares of Carmike Cinemas from $13.50 to $17.00 in a research note to investors on Wednesday, April 4th. They now have an “outperform” rating on the stock. Separately, analysts at Maxim Group raised their price target on shares of Carmike Cinemas from $13.00 to $20.00 in a research note to investors on Monday, April 2nd. They now have a “buy” rating on the stock. Finally, analysts at Barrington Research raised their price target on shares of Carmike Cinemas to $17.00 in a research note to investors on Wednesday, March 14th.
Carmike Cinemas traded down 0.14% on Wednesday, hitting $14.02. Carmike Cinemas has a 1-year low of $5.14 and a 1-year high of $14.92. The company’s market cap is $181.8 million.
The company last announced its quarterly results on Monday, March 12nd. It reported $0.14 earnings per share (EPS) for the previous quarter, beating the Thomson Reuters consensus estimate of $0.08 EPS by $0.06. The company’s quarterly revenue was up 4.3% on a year-over-year basis. Analysts expect that Carmike Cinemas will post $0.43 EPS next quarter.
Carmike Cinemas, Inc. is a motion picture exhibitor in the United States. As of December 31, 2010, the Company owned, operated or had an interest in 239 theatres with 2,236 screens located in 36 states.